SpringerProtocols: Abstract: Practical Considerations in the Exploitation of Passive Tumor Targeting

Practical Considerations in the Exploitation of Passive Tumor Targeting

By: Gillian D. Thomas²

Abstract

Full Text

Download PDF (127K)

Specific targeting of radioisotopes or toxic drugs to tumors for cancer detection and treatment is an enticing but elusive goal. It has proved difficult to achieve adequate concentration ratios between tumor and normal tissues to improve on standard diagnostic and therapeutic methods.

Affiliation(s): (2) Department of Clinical Oncology, Derbyshire Royal Infirmary, Derby, UK

Book Title: Drug Targeting: Strategies, Principles, and Applications

Series: Methods in Molecular Medicine | Volume: 25 | Pub. Date: Apr-21-2000 | Page Range: 97-112 | DOI: 10.1385/1-59259-075-6:97

Subject: Pharmacology/Toxicology

References

Download References

1.	Bierwaltes, W. H. (1982) The treatment of thyroid carcinoma with radioactive iodine. Semin. Nucl. Med. 23, 43.

2.	Hofnagel, C. A. and Lewington, V. J. (1994) MIBG therapy, in Nuclear Medicine in Clinical Diagnosis and Treatment (Murray and Ell, eds.), Churchill Livingstone, Edinburgh, Scotland.

3.	Bauer, F. K., Tubis, M., and Thomas, H. B. (1955) Accumulation of homologous radioiodinated albumin in experimental tumours. Proc. Soc. Exper. Biol. Med. 90, 140–142.

4.	Hoffer, P. P. and Gottschalk A. (1974) Tumour scanning agents. Semin. Nucl. Med. 4, 305–316. <Occurrence Type="DOI"><Handle>10.1016/S0001-2998(74)80017-6</Handle></Occurrence>

5.	Quastel, M. R., Richter, A. M., and Levy, J. G. (1990) Tumour scanning with Indium-111 dihaematoporphyrin ether. Br. J. Cancer 62, 885–890.

6.	Zwi, L. J., Baguley, B. C., Gain, J. B., and Wilson, W. R. (1990) Necrosis in non-tumour tissues caused by flavone acetic acid and 5,6-dimethyl xanthenone acetic acid. Br. J. Cancer 62, 932–934.

7.	Nakajo, M., Kobayashi, H., Shimabukuro, K., Shirono, K., Sakata, H., Taguchi, M., Uchiyama, N., Sonoda, T., and Shinohara, S. (1988) Biodistribution of in vivo kinetics of Iodine-131 lipiodol infused via the hepatic artery of patients with hepatic cancer. J. Nucl. Med. 29, 1066–1077.

8.	Briele, B., Hotze, A., Oehr, P., Biersack, H. J., Rosanowski, F., Gorgulla, W., and Herberhold, C. (1990) Tumour imaging with labelled liposomes. Lancet 336, 875–876. <Occurrence Type="DOI"><Handle>10.1016/0140-6736(90)92379-V</Handle></Occurrence>

9.	Widder, K. J., Morris, R. M., Poore, G. A., Howard, D. P., and Senyei, A. E. (1983) Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats. Eur. J. Cancer Clin. Oncol. 19, 135–139. <Occurrence Type="DOI"><Handle>10.1016/0277-5379(83)90408-X</Handle></Occurrence>

10.	Evers, B. M., Parekh, D., Townsend, C. M., Jr., and Thompson, J. C. (1991) Somatostatin and analogues in the treatment of cancer. Ann. Surg. 213, 190–198.

11.	Mather, S. J. and Ward, B. G. (1987) High efficiency iodination of monoclonal antibodies for radiotherapy. J. Nucl. Med. 28, 1034–1036.

12.	Anderson, W. T., and Strand, M. (1978) Radiolabelled antibody: iodine versus radiometal chelates. NCI Monogr. 3, 149–151.

13.	Hillier, A. P. (1972) Deiodination of thyroid hormones by the perfused rat liver. J. Physiol. 222, 475–485.

14.	Pernis, B. (1985) Internalisation of lymphocyte membrane components. Immunol. Today 6, 45–49. <Occurrence Type="DOI"><Handle>10.1016/0167-5699(85)90046-5</Handle></Occurrence>

15.	Hnatowich, D. J., Virxi, F., and Doherty, P. W. (1985) DTPA-coupled antibodies labeled with yttrium-90. J. Nucl. Med. 26, 503–509.

16.	Stewart, J. S., Hird, V., Snook D., Sullivan, M., Myers, M. J., and Epenetos, A. A. (1988) Intraperitoneal 131I-and 90Y-labelled monoclonal antibodies for ovarian cancer: pharmacokinetics and normal tissue dosimetry. Int. J. Cancer (Suppl. 3), 71–76.

17.	Vriesendorp, H. M., Herpst, J. M., Leichner, P. K., Klein, J. L., and Order, S. E. (1989) Polyclonal 90Yttrium labeled antiferritin for refractory Hodgkin’s disease. Int. J. Rad. Oncol. Biol. Phys. 17, 815–821.

18.	Rainsbury, R. and Westwood, J. (1982) Tumour localisation with monoclonal antibody radioactivity labelled with metal chelate rather than iodine. Lancet II: 1347–1348. <Occurrence Type="DOI"><Handle>10.1016/S0140-6736(82)91553-7</Handle></Occurrence>

19.	Meares, C. F., Moi, M. K., Diril, H., Kukis, D. L., McCall, M. J., Deshpande, S. V., DeNardo, S. J., Snook, D., and Epenetos, A. A. (1990) Macrocyclic chelates of radiometals for diagnosis and therapy. Br. J. Cancer 62(Suppl. X), 21–26.

20.	Alvarez, V. L., Wen, M. L., Lee, C., Lopes, A. D., Rodwell, J. D., and McKearn, T. J. (1986) Site-specifically modified ^IIIIndium labeled antibodies give low liver backgrounds and improved radioimmunoscintigraphy. Int. J. Rad. Appl. Instrum. [B] 13, 347–352.

21.	Otsuka, F. L. and Fleishman, J. B. (1986) Comparative studies using ¹²⁵I-and ^IIIInlabeled monoclonal antibodies. Eur. J. Nucl. Med. II, 295–299.

22.	Epenetos, A. A., Britton, K. E., Mather, S., Shepherd, J., Granowska, M., Taylor-Papadimitriou, J., Nimmon, C. C., Durbin, H., Hawkins, L. R., Malpas, J. S., and Bodmer, W. F. (1982) Targeting of Iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet II, 999–1004. <Occurrence Type="DOI"><Handle>10.1016/S0140-6736(82)90046-0</Handle></Occurrence>

23.	Zamora, P. O., Bender, H., Knapp, F. F. (R.) Jr., and Biersack, H. J. (1996) Radiotherapy of intrathoracic carcinoma xenografts with ¹⁸⁸Re-RC-160, a somatostatin analogue. Tumor Targeting 2, 49–59.

24.	Cole, W. C., DeNardo, S. J., Meares, C. F., McCall, M. J., DeNardo, G. L., Epstein, A. L., O’Brien, H. A., and Moi, M. K. (1987) Comparative serum stability of radiochelates for antibody radiopharmaceuticals. J. Nucl. Med. 28b 83–90.

25.	Schwarz, A., Streinstrasser, A., and Hoechst, A. G. (1987) A novel approach to Tc99m-labelled monodonal antibodies. J. Nucl. Med. 28, 721.

26.	Baum, R. P., Hertel, A., Lorenz, M., Schwarz, A., Encke, A., and Hor, G. (1989) ^99mTc-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results. Nucl. Med. Commun. 10, 345–352.

27.	Ott, R. J., Grey, L. J., Zivanovic, M. A., Flower, M. A., Trott, N. G., Moshakis, V., Coombes, R. C., Omerod, M. C., Westwood, J. H., and McCready, V. R. (1983) The limitations of the dual radionuclide subtraction technique for the external detection of tumour by radioiodine-labelled antibodies. Br. J. Radiol. 56, 101–108.

28.	Chandler, S. T. and Anderson, P. (1987) A method for thresholding subtracted images in radiolabelled-antibody imaging. Br. J. Radiol. 60, 881–886.

29.	Granowska, M., Nimmon, C. C., Britton, K. E., Crowther, M., Mather, S. J., Slevin, M. L., and Shepherd, J. H. (1988) Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy. J. Nucl. Med. 29, 599–607.

30.	Serafini, A. N., Goldenberg, D. M., Higinbotham-Ford, E. A., Silberstein, E. B., Van Heertum, R. L., Kotler, J. A., Balasubramanian, N., Garty, I., and Wlodkowski, T. (1989) A multicenter trial of cancer imaging with fragments of CEA monoclonal antibodies. J. Nucl. Med. 82, 748.

31.	Goodwin, D., Meares, C., Diamanti, C., McCall, M., Lai, X., Torti, F., McTigue, M., and Martin, B. (1984) Use of specific antibody for rapid clearance of circulating blood background from radiolabelled tumour imaging proteins. Eur. J. Nucl. Med. 9, 209–215.

32.	Pedley, P. B., Dale, R., Boden, J. A., Begent, R. H., Keep, P. A., and Green, A. J. (1989) The effect of second antibody clearance on the distribution and dosimetry of radiolabelled anti-CEA antibody in a human colonic tumor xenograft model. Int. J. Cancer 43, 713–718.

33.	Wahl, R. L., Geatti, O., Liebert, M., Wilson, B., Shreve, P., and Beers, B. A. (1987) Kinetics of interstitially administered monoclonal antibodies for purposes of lymphoscintigraphy. J. Nucl. Med. 28, 1736–1744.

34.	Sutherland, R. M., Buchegger, F., Schreyer, M., Vacca, A., and Mach, J. P. (1987) Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellu-lar spheroids. Cancer Res. 47, 1627–1633.

35.	Searle, F., Adam, T., and Boden, J. A. (1986) Distribution of intact and Fab₂ fragments of anti-human chorionic gonadotrophin antibodies in nude mice bearing human choriocarcinoma xenografts. Cancer Immunol. Immunother. 21, 205–208.

36.	Burraggi, G. L., Callegaro, L., Marianari, G., Turrin, A., Cascinelli, N., Attili, A., Bombardieri, E., Terno, G., Plassio, G., Dovis, M, Mazzuca, N., Natali, P. G., Scassallati, G. A., Rosa, U., and Ferrone, S. (1985) Imaging with ¹³¹I-labelled monoclonal antibodies to a high molecular weight melanoma-associated antigen in patients with melanoma: efficiency of whole immunoglobulin and its F(ab)₂ fragments. Cancer Res. 45, 3378–3387.

37.	Rowlinson-Busza, G., Deonarain, M. P., and Epenetos, A. A. (1996) Comparison of intact monoclonal antibody, its F(ab’)₂ and Fab fragments and recombinant single chain Fv in a human tumour xenograft model. Tumour Targeting 2, 37–48.

38.	Sharkey, R. M., Primus, F. J., Shochat, D., and Goldenberg, D. M. (1988) Comparison of tumour targeting of mouse monoclonal and goat polyclonal antibodies to carcinoembryonic antigen in the GW-39 human tumour-hamster host model. Cancer Res. 48, 1823–1828

39.	Goldenberg, D. M., Goldenberg, H., Sharkey, R. M., Lee, R. E., Higginbotham-Ford, E., Horowitz, J. A., Hall, T. C., Pinsky, C. M., and Hansen, H. J. (1989) Imaging of colorectal carcinoma with radiolabeled antibodies. Semin. Nucl. Med. 19, 262–281. <Occurrence Type="DOI"><Handle>10.1016/S0001-2998(89)80020-0</Handle></Occurrence>

40.	Delgado, C., Pedley, B., Herraez, A., Boden, R., Boden, J. A., Keep, P. A., Chester, K. A., Fisher, D., Begent, R. H., and Francis, G. E. (1996) Enhanced tumour specificity of an anti-carcinoembryonic antigen Fab’ fragment by poly(ethylene glycol) (PEG) modification. Br. J. Cancer 73, 175–182.

41.	Neri, D., de Lalla, C., Petrul, H., Soldani, P., di Stefano, A., Lozzi, L., Neri, G., and Neri, P. (1995) Engineering recombinant bifunctional antibodies. Tumour Targeting 1, 189–194.

42.	Green, N. M. (1963) Avidin. The nature of the biotin-binding site. Biochem. J. 89, 599–609.

43.	Hnatowich, D. J., Virzi, F., and Rusckowski, M. (1987) Investigations of avidin and biotin for imaging applications. J. Nucl. Med. 28, 1294–1302.

44.	Pimm, M. V., Fells, H. F., Perkins, A. C., and Baldwin, R. W. (1988) Iodine-131 and indium-111 labelled avidin and streptavidin for pre-targeted immuno-scintigraphy with biotinylated antitumour monoclonal antibody. Nucl. Med. Commun. 9, 931–941.

45.	Bagshawe, K. D., Sharma, S. K., Springer, C. J., and Antoniw, P. (1995) Antibody directed enzyme prodrug therapy: a pilot-scale clinical trial. Tumour Targeting 1, 17–30.

46.	Pimm, M. V. (1988) Drug-antibody conjugates for cancer therapy: potentials and limitations. Crit. Rev. Ther. Drug Carrier Syst. 5, 189–227.

47.	Weinstein, J. N., Steller, M. A., Keenan, A. M., Covell, D. G., Kay, M. E., Sieber, S. M., Oldham, R. K., Hwang, K. M., and Parker, R. J. (1983) Monoclonal antibodies in the lymphatics: selective delivery to lymph node metastases of a solid tumor. Science 222, 423–426.

48.	Epenetos, A. A., Courtenay-Luck N., Pickering, D., Hooker, G., Durbin, H., Lavender, J. P., and McKenzie, C. G. (1985) Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. Br. Med. J. 290, 1463–1466.

49.	Coakham, H. B., Richardson, R. B., Davies, A. G., Boume, A. P., Moseley, R. P., Kemshead, J. T., and Lashford, L. (1986) Antibody-guided radiation therapy via the CSF for malignant meningitis. Lancet II, 860,861.

50.	Pectasides, D., Stewart, S., Courtenay-Luck N., Rampling, R., Munro, A. J., Krausz, T., Dhokia, B., Snook D., Hooker, G., Durbin, H., Taylor-Papadimitriou, J., Bodmer, W. F., and Epenetos, A. A. (1986) Antibody-guided irradiation of malignant pleural and pericardial effusions. Br. J. Cancer 53, 727–732.

51.	Hnatowich, D. J., Chinol, M., Siebecker, D. A., Gionet, M., Griffin, T., Doherty, P. W., Hunter, R., and Kase, K. R. (1988) Patient distribution of intraperitoneally administered yttrium-90-labeled antibody. J. Nucl. Med. 29, 1428–1434.

52.	Wahl, R. L., Barrett, J., Geatti, O., Liebert, M., Wilson, B. S., Fisher, S., and Wagner, J. G. (1988) The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage. Cancer Immunol. Immunother. 26, 187–201.

53.	Smith, D. B., Mosely, R. P., Begent, R. H. J., Coakham, H. B., Glaser, M. G., Dewhurst, S., Kelly, A., and Bagshawe, K. D. (1990) Quantitative distribution of ¹³¹I-labelled monoclonal antibodies administered by the intraventricular route. Eur.J. Cancer 26, 129–136.

54.	Press, O. W., Eary, J. F., Badger, C. C., Martin, P. J., Appelbaum, F. R., Levy, R., Miller, R., Brown, S., Nelp, W. B., Krohn, K. A., Fisher, D., DeSantes, K., Porter, B., Kidd, P., Thomas, E. D., and Bernstein, I. D. (1989) Treatment of refractory non-Hodgkin’s lym-phoma with radiolabeled MB-1 (anti-CD37) antibody. J. Clin. Oncol. 7, 1027–1038.

55.	Jain, R. K. and Baxter, L. T. (1988) Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumours: significance of raised interstitial pressure. Cancer Res. 48, 7022–7032.

56.	Maeda, H. (1991) SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv. Drug Delivery Rev. 6, 181–202. <Occurrence Type="DOI"><Handle>10.1016/0169-409X(91)90040-J</Handle></Occurrence>

57.	Braunschweiger, P. G. and Schiffer, L. M. (1986) Effect of dexamethasone on vascular function in RIF-1 tumors. Cancer Res. 46, 3299–3303.

58.	Leenders, K. L., Beaney, R. P., Brooks, D. J., Lammertsma, A. A., Heather, J. D., and McKenzie, C. G. (1985) Dexamethasone treatment of brain tumour patients: effects on regional cerebral blood flow, blood volume, and oxygen utilisation. Neurology 35, 1610–1616.

59.	Attard, A. R., Thomas, G. D., Chappell, M. J., Taylor, D. N., Baum, R. P., Dykes, P. W., Godfrey, K. R., Fraser, I. A., and Bradwell, A. R. (1991) Effect of high dose, high affinity antibody and dexamethasone on antibody uptake by colorectal cancer: results of a pilot study. Antibody, Immunoconj. Radiopharmaceut. 4, 871–876.

60.	Curti, B. D., Urba, W. J., Alvord, W. G., et al. (1993) Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment. Cancer Res. 53, 2204.

61.	Schultz, K. R., Badger, C. C., Dombi, G. W., Greenberg, P. P., and Bernstein, I. D. (1992) Effect of interleukin-2 on biodistribution of monoclonal antibody in tumour and normal tissues in mice bearing SL-2 thymoma. J. Natl. Cancer Inst. 15, 109–112.

62.	Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., and Winter, G. (1986) Replacing the complementarily-determining regions in a human antibody with those from a mouse. Nature 321, 522–525.

63.	Hamblin, T. J., Cattan, A. R., Glennie, M. J., Mackenzie, M. R., Stevenson, F. K., Watts, H. F., and Stevenson, G. T. (1987) Initial experience in treating human lymphoma with a chimeric univalent derivative of monoclonal anti-idiotype antibody. Blood 69, 790–797.

64.	McCabe, R. P., Peters, L. C., Haspel, M. V., Pomato, N., Carrasquillo, J. A., and Hanna, M. G., Jr. (1988) Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors. Cancer Res. 48, 4348–4353.

65.	Ledermann, J. A., Begent, R. H. J., Bagshawe, K. D., Riggs, S. J., Searle, F., Glaser, M. G., Green, A. J., and Dale, R. G. (1988) Repeated antitumour antibody therapy in man with suppression of the host response by Cyclosporin A. Br. J. Cancer 58, 654–657.

66.	Zimma, A. M., Rosen, S. T., Spies, S. M., Golman-Leilin, R., Kazikiewicz, J. M., Silverstein, E. A., and Kaplan, E. H. (1988) Radioimmunotherapy of patients with cutaneous T-cell lymphoma using an iodine-131-labeled monoclonal antibody: analysis of retreatment following plasmapheresis. J. Nucl. Med. 19, 174–180.

67.	Rosenthal, K. C., Tompkins, W. A. F., and Rawls, W. E. (1980) Factors affecting the expression of carcinoembryonic antigen at the surface of cultured human colon carcinoma cells. Cancer Res. 40, 4774–4750.

68.	Iacobelli, S., Scambia, G., Natoli, C., Benedetti Panici, P., Baiocchi, G., Perone, L., and Mancuso, S. (1988) Recombinant human leucocyte interferon-α 2b stimulates the synthesis and release of a 90K tumor-associated antigen in human breast cancer cells. Int. J. Cancer 42, 182–184.

69.	Rowlinson, G., Balkwill, F., Snook, D., Hooker, G., and Epenetos, A. A. (1986) Enhancement by gamma-interferon of in vivo tumour radiolocalization by a monoclonal antibody against HLA-DR antigen. Cancer Res. 46, 6413–6417.

70.	Wong, J. Y. C., Mivechi, N. F., Paxton, R. J., Williams, L. E., Beatty, B. G., Beatty, J. D., and Shively, J. E. (1989) The effects of hyperthermia on tumor carcinoembryonic antigen expression. Int. J. Radiol. Biol. Phys. 17, 803–808.

71.	Shi, Z. R., Tsao, D., and Kim, Y. S. (1983) Subcellular distribution, synthesis, and release of carcinoembryonic antigen in cultured human colon adenoma cell lines. Cancer Res. 43, 4045–4049.

72.	Goldenberg, D. M., Kim, E. E., DeLand, F. H., Spremulli, E., Nelson, M. O., Cockerman, J. P., Primus, F. J., Corgan, R. L., and Alpert, E. (1980) Clinical studies on the radioimmunodetection of tumours containing alpha-fetoprotein. Cancer 45, 2500–2505. <Occurrence Type="DOI"><Handle>10.1002/1097-0142(19800515)45:10<2500::AID-CNCR2820451006>3.0.CO;2-J</Handle></Occurrence>

73.	Katoh, Y., Nakata, K., Kohno, K., Shima, M., Satoh, A., Kusumoto, Y., Ishii, N., Kohji, T., Shiku, H., and Nagataki, S. (1990) Immunoscintigraphy of human tumors transplanted in nude mice with radiolabeled anti-ras p21 monoclonal antibodies. J. Nucl. Med. 31, 1520–1526.

74.	Krizan, Z., Murray, J. L., Hersh, E. M., Rosenblum, M. G., Glenn, H. J., Gschwind, C. R., and Carlo, D. J. (1985) Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognising separate cell surface antigenic determinants. Cancer Res. 45, 4904–4909.

75.	Baum, R. P, Lorenz, M., Hottenrott, C., Albrecht, M., Senekowitch, R., Happ, J., Hertel, A., Spitz, J., and Hor, G. (1988) Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125. Int. J. Biol. Markers 3, 177–184.

76.	Durrant, L. G., Robins, R. A., and Baldwin, R. W. (1989) Flow cytometric screening of monoclonal antibodies for drug or toxin targeting to human cancer. J. Natl. Cancer Inst. 9, 688–696.

77.	Brown, M. S., Anderson, R. G. W., and Goldstein, J. L. (1983) Recycling receptors: the round-trip itinerary of migrant membrane proteins. Cell 32, 663–667. <Occurrence Type="DOI"><Handle>10.1016/0092-8674(83)90052-1</Handle></Occurrence>

78.	Glennie, M. J. and Stevenson, G. T. (1982) Univalent antibodies kill tumour cells in vitro and in vivo. Nature 295, 712–714.

79.	Nadler, L. M., Stashenko, P., Hardy, R., Kaplan, W. D., Burton, L. N., Kufe, D. W., Antman, K. H., and Schlossman, S. F. (1980) Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res. 40, 3147–3154.

80.	Miller, R. A., Maloney, D. G., McKillop, J., and Levy, R. (1981) In vivo effects of murine hybridoma monoclonal antibody in a patient with T cell leukaemia. Blood 58, 78–86.

81.	Primus, F. J., Bennett, S. J., Kim, E. E., DeLand, F. H., Zahn, M. C., and Goldenberg, D. M. (1980) Circulating immune complexes in cancer patients receiving goat radiolocalising antibodies to carcinoembryonic antigen. Cancer Res. 40, 497–501.

82.	Bosslet, K., Steinstrasser, A., Schwarz, A., Harthus, H. P., Luben, G., Kuhlmann, L., and Sedlacek, H. H. (1988) Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas. Eur. J. Nucl. Med. 14, 523–528.

83.	Stevenson, G. T., Glennie, M. J., Hamblin, T. J., Lane, A. C., and Stevenson, F. K. (1988) Problems and prospects in the use of lymphoma idiotypes as therapeutic targets. Int. J. Cancer Suppl. 3, 9–12.

84.	Mason, D. W. and Williams, A. F. (1980) The kinetics of antibody binding to membrane antigens in solution and at the cell surface. Biochem. J. 187, 1–20.

85.	Rostock, R. A., Klein, J. L., Kopher, K. A., and Order, S. E. (1984) Variables affecting the tumor localization of 131 I-anti-ferritin in experimental hepatoma. Am. Clin. Oncol. 6, 9–18.

86.	Eger, R. R., Covell, D. G., Carrasquillo, J. A., Abrams, P. G., Foon, K. A., Reynolds, J. C., Schroff, R. W., Morgan, A. C., Larson, S. M., and Weinstein, J. N. (1987) Kinetic model for the biodistribution of an 111Indium-labeled monoclonal antibody in humans. Cancer Res. 47, 3328–3336.

87.	Murray, J. L., Lamki, L. M., Shanken, L. J., Blake, M. E., Plager, C. E., Benjamin, R. S., Schweighardt, S., Unger, M. W., and Rosenblum, M. G. (1988) Immuno-specific saturable clearance mechanisms for Indium-111-labeled anti-melanoma monoclonal antibody 96. 5 in humans. Cancer Res. 48, 4417–4422.

88.	Carrasquillo, J. A., Abrams, P. G., Schroff, R. W., Reynolds, J. C., Woodhouse, C. S., Morgan, A. C., Keenan, A. M., Foon, K. A., Perentis, P., Marshall, S., Horowitz, M., Szymendera, J., Englert, J., Oldham, R. K., and Larson, S. M. (1988) Effect of antibody dose on the imaging and biodistribution of Indium-111 9.2.27 anti-melanoma monoclonal antibody. Nucl. Med. 29, 39–17.

89.	Chabot, G. G., Bissery, M.-C., Corbett, T. H., Rutkowski, K., and Baker, L. H. (1989) Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice. Cancer Chemother. Pharmacol. 24, 15–22.

90.	Chow, D. D., Essien, H. E., Padki, M. M., and Hwary, K. J. (1989) Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect. J. Pharmacol. Exp. Ther. 248, 506–513.

91.	Byers, V. S., Pimm, M. V., Pawluczyk, I. Z., Lee, H. M., Scannon, P. J., and Baldwin, R. W. (1987) Biodistribution of ricin-antibody conjugates and influence of hepatic blocking agents. Cancer Res. 47, 5277–5283.

92.	Covell, D. G., Barbet, J., Holton, O. D., Black, C. D. V., Parker, R. J., and Weinstein J. N. (1986) Pharmacokinetics of monoclonal immunoglobulin G1, F(ab’)₂, and Fab’ in mice. Cancer Res. 46, 3969–3978.

93.	Oie, S. and Tozer, T. N. (1979) Effect of altered plasma protein binding on appar-ent volume of distribution. J. Pharm. Sci. 68, 1203–1205.

94.	Rowland, M. (1984) Physiologic pharmacokinetic models: relevance, experience and future trends. Drug Metab. Rev. 15, 55–74.

95.	DiStefano, J. J. and Chang, R. F. (1971) Computer simulation of thyroid hormone binding, distribution, and disposal dynamics in man. Am. J. Physiol. 221, 1529–1544.

96.	Ishikawa, H., Maeda, T., Hikita, H., and Miyatake, K. (1988) The computerised derivation of rate equations for enzyme reactions on the basis of the pseudo-steady-state assumption and the rapid-equilibrium assumption. Biochem. J. 251, 175–181.

Comments (Loading...)

Post comment/View all comments